SANTA CLARA, Calif., Sept. 2, 2021 /PRNewswire/ — An estimated 375 million computed tomography (CT) procedures are carried out globally each year, increasing annually by 3%–4%. The rapidly evolving needs of clinicians and radiologists coupled with technology advancements such as photon-counting detector technology, machine learning, deep learning, and spectral imaging have transformed the landscape of the global CT industry. The CT market worldwide is witnessing a gradual shift from low-end CT scanners to mid-high (64 slice) and high-end (128 slice and above) scanners, primarily due to CT technology innovations in reducing radiation dosage and expanding clinical applications in vascular, oncology, cardiac, and breast cancer imaging. As a result, the global CT market is expected to reach $6.14 billion by 2025 from $4.16 billion in 2020, registering steady growth at a compound annual growth rate (CAGR) of 8.1%.

For further information on this analysis, Global Computed Tomography Growth Opportunities, please visit: http://frost.ly/69q

“High-end CT purchases by university/academic and public hospitals in North America, Western Europe, and Japan are expected to propel the high-end CT segment revenue,” said Poornima Srinivasan, Healthcare & Life Sciences Consultant at Frost & Sullivan. “The 16- to 64-slice scanner shipments to diagnostic imaging centers in developing regions of LATAM, India and China are increasing and anticipated to experience moderate growth over the forecast period.”

Srinivasan added: “CT was at the forefront of combat against the COVID-19 pandemic as the majority of countries immediately installed CT for lung screening. Despite new purchases, the capacity of traditional unit shipments per year did not yield its full potential. As such, there is an expected pent-up demand for CT to fulfill needs-based requirements during the forecast period.”

The trend of upgrading existing scanners to high-end scanners will present the following growth opportunities for market participants:

• Increasing use of traditional and mobile CT in lung cancer screening: Mobile CT can increase overall CT use cases, widen the market for participants, and present a business opportunity for leading manufacturers with a broad CT portfolio.
• CT penetration in cardiac centers: With reimbursement approval from the current procedure terminology (CPT) and European regulations, cardiac imaging has taken a significant stride toward CT scanning.
• Artificial intelligence (AI)-powered CT scanners are promising cancer detection tools: A significant uptake of AI-based CT is anticipated by 2025 due to its efficiency and ability to handle large patient volumes. Regulatory approvals for these solutions are expected in the next one to two years. CT manufacturers should capitalize on the first-mover advantage by offering transparent and flexible pricing and partnering with start-ups.
• Global Computed Tomography Growth Opportunities is the latest addition to Frost & Sullivan’s Healthcare & Life Sciences research and analyses available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.

About Frost & Sullivan

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Global Computed Tomography Growth Opportunities

MFC

Contact:
Mariana Fernandez
Corporate Communications
E: Mariana.Fernandez@frost.com
http://www.frost.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/high-end-global-computed-tomography-purchases-to-propel-the-high-end-ct-segment-revenue-301367872.html

SOURCE Frost & Sullivan